<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B983A43-F458-4ACB-8CB1-0A81CFB1293B"><gtr:id>7B983A43-F458-4ACB-8CB1-0A81CFB1293B</gtr:id><gtr:name>Sareum</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Medicine and Biomedical Science</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B983A43-F458-4ACB-8CB1-0A81CFB1293B"><gtr:id>7B983A43-F458-4ACB-8CB1-0A81CFB1293B</gtr:id><gtr:name>Sareum</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/34BD1A18-C9F6-41AE-9711-C61DF6EF2D86"><gtr:id>34BD1A18-C9F6-41AE-9711-C61DF6EF2D86</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Eyers</gtr:surname><gtr:orcidId>0000-0002-9220-2966</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G120%2F1030"><gtr:id>A950D8D3-A4AF-4907-A4FD-6D3439B4D54C</gtr:id><gtr:title>Regulation of Mps1, a protein kinase required for the spindle assembly checkpoint.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G120/1030</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Alarmingly, one in three people will be diagnosed with cancer during their lifetime, and in 2003 almost 300,000 new cancer cases were reported in the UK. One of the major cytological differences between normal cells and tumour cells is the abnormal chromosome complement found in the latter, suggestive of a direct link between aneuploidy and cancer. Moreover, it is now clear that aneuploid cells are produced due to chromosome missegregation during cell division. The process of chromosome segregation is monitored and regulated by the spindle assembly checkpoint, a molecular protein assembly that inhibits cell division until chromosome alignment is complete. Mutations in several checkpoint genes have been directly linked to cancer, and specific inhibition of checkpoint components has recently been validated as a potent mechanism for selectively killing tumour cells. 
 Mps1 is a conserved protein kinase whose activity is essential for the spindle assembly checkpoint in all organisms examined, and Mps1 enzymatic activity is subject to regulation by phosphorylation. However, the precise mechanism of Mps1 regulation by phosphorylation is unknown, and this is a direct consequence of our limited biochemical understanding of the checkpoint. The main aim of this study is to develop a focused research programme to investigate checkpoint components at the biochemical level, beginning with the protein kinase Mps1.
 I have discovered that bacterial Mps1 can be employed as a model to understand how Mps1 kinase activity is controlled and regulated. To this end, four key objectives will be fulfilled:
1) Molecular dissection of the in vitro mechanism of Mps1 regulation by phosphorylation 
2) Analysis of endogenous Mps1 regulation in human cells and Xenopus extracts
3) Regulation of Mps1 activity by exogenous factors present in Xenopus egg extracts
4) Investigation of Mps1 function in human cells by chemical genetics.
 A combination of mass spectrometry, mutagenesis and kinase assays will be exploited to examine the first two problems, while biochemical purification and Xenopus extract manipulation will be used to complete the third. Xenopus egg extracts have played a crucial role in advancing our biochemical understanding of the cell cycle, and will be invaluable for these studies. Finally, a cell permeable small molecule kinase inhibitor and a mutant Mps1 target will be exploited to directly assess the physiological regulation of Mps1 in human cells. This study will permit the molecular dissection of requirements for Mps1 activity and create a platform for subsequent studies of other therapeutically relevant protein kinases whose activity is important for diseases such as cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2011-01-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>574513</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sareum</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sareum Pharmaceuticals</gtr:description><gtr:id>A1EF35E2-D984-4A84-9FC6-21BC9BA5629C</gtr:id><gtr:impact>Publications (3)</gtr:impact><gtr:outcomeId>YQAy5esdZ7x-1</gtr:outcomeId><gtr:partnerContribution>PhD student training, use of facilities (X-ray), scientific meetings to share knowledge.</gtr:partnerContribution><gtr:piContribution>Sharing of reagents and kinase biology knowledge. In my lab, we used kinase assays to assay novel kinase inhibitors and help design new pre-clinical inhibitors.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>TV interview-Manchester</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>47CEE3EB-060B-48B1-BE2F-A54353C211A1</gtr:id><gtr:impact>Gave TV interview pertaining to our work, funded by the MRC, explaining basics and importance of fundamental applied biological research.

Wide publicity, good links for the future.</gtr:impact><gtr:outcomeId>1EE5B3CB63A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Newspaper- Sunday Express</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>490921E1-D410-4308-B0C3-940DEA287E2C</gtr:id><gtr:impact>Wrote an article entitled: 'Living proof we will beat cancer.' Obtained a quote from Professor Dario Alessi (MRC-PPU, University of Dundee) to add strength to the article.

Large public dissemination; estimated readership 1 million</gtr:impact><gtr:outcomeId>566865C6390</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BBCCE110-D620-46A7-865E-591A93C83ACB</gtr:id><gtr:impact>A press release was picked up around the world (eg India, USA), stating that we had solved the 3D structure of a new protein kinase (Mps1)

Lots of good publicity.</gtr:impact><gtr:outcomeId>YJUQvpnbC2r</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>155000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Research Grant</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>342567F6-43BC-4FDA-B7FC-E95110FBF875</gtr:id><gtr:outcomeId>C32A2B224D70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>168000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>YCR Project Grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Yorkshire Cancer Research</gtr:fundingOrg><gtr:id>14C8F574-B2ED-4BA2-8C0A-DCEF95F520B0</gtr:id><gtr:outcomeId>8F76B544AE20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Nature/UCSD Mps1 molecule pages published on nature website as part of web-driven project to describe all human proteins. Provides a succint review of Mps1 biology.</gtr:description><gtr:id>AF8CDBCA-9176-4BB3-AF72-B5D573B5FC21</gtr:id><gtr:impact>Will be freely available to anyone wishing for up-to-date information of Mps1 kinase.</gtr:impact><gtr:outcomeId>E4736B572F8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mps1 Molecule Pages</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Publically-published 3D structure of Mps1 in complex with small molecule inhibitors.</gtr:description><gtr:id>4987F329-4EE8-4644-ACE3-1F962EC80A73</gtr:id><gtr:impact>None as yet. Expected to aid Mps1 drug discovery markedly</gtr:impact><gtr:outcomeId>F9006FBB477</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>3D stucture of Mps1</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibodies that recognise activated human Mps1</gtr:description><gtr:id>BC345332-06A9-4B7A-827F-26B369342798</gtr:id><gtr:impact>Multiple publications with collaborators, publications and knowledge transfer</gtr:impact><gtr:outcomeId>A58298C280B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Phosphospecific antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>51E37DB8-2CCC-4A03-86A7-9857C30020D3</gtr:id><gtr:title>DRP-1 is required for BH3 mimetic-mediated mitochondrial fragmentation and apoptosis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4611475df200eb5d57ddc81bbaf545a8"><gtr:id>4611475df200eb5d57ddc81bbaf545a8</gtr:id><gtr:otherNames>Milani M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58b42a0d06cad9.90421732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD61A37D-9AEC-4724-BE6E-2766362CEADA</gtr:id><gtr:title>Dawn of the dead: protein pseudokinases signal new adventures in cell biology.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dfc38e1876abc9625afc96ed7e7a1e8"><gtr:id>9dfc38e1876abc9625afc96ed7e7a1e8</gtr:id><gtr:otherNames>Eyers PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_14412_22_23863165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B74F6EEA-E19D-4660-BF52-0BBA5577877A</gtr:id><gtr:title>VX-680 inhibits Aurora A and Aurora B kinase activity in human cells.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63d35cb446702cc244a656ef037242ea"><gtr:id>63d35cb446702cc244a656ef037242ea</gtr:id><gtr:otherNames>Tyler RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>BF7E8D885F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>585DBCFF-0C6E-488C-B871-EBDFD6DFCF0A</gtr:id><gtr:title>Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a40f0a365b211e74b0c0e37d564203ff"><gtr:id>a40f0a365b211e74b0c0e37d564203ff</gtr:id><gtr:otherNames>Chu ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>36048B509B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69B889D9-464F-4D66-B9DA-8AAC820CBE68</gtr:id><gtr:title>KinView: a visual comparative sequence analysis tool for integrated kinome research.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2b330f2baa870f4a4e8801c2760d0e"><gtr:id>7d2b330f2baa870f4a4e8801c2760d0e</gtr:id><gtr:otherNames>McSkimming DI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>58b42a0df41127.86818006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED4C207A-C55E-4044-B8D6-9BD1D784290F</gtr:id><gtr:title>Pseudokinases: update on their functions and evaluation as new drug targets.</gtr:title><gtr:parentPublicationTitle>Future medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aabe497d7b3d1820da77665967bdd709"><gtr:id>aabe497d7b3d1820da77665967bdd709</gtr:id><gtr:otherNames>Byrne DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-8919</gtr:issn><gtr:outcomeId>58b42a0e2d1a55.72319747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C6AFDFA-AD9A-480C-9D86-3E26EF5185AF</gtr:id><gtr:title>Discovery and exploitation of inhibitor-resistant aurora and polo kinase mutants for the analysis of mitotic networks.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3367d2b5df7411b9fec5892f66aa5685"><gtr:id>3367d2b5df7411b9fec5892f66aa5685</gtr:id><gtr:otherNames>Scutt PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5BF9B546E46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8DE24C6-87F6-4739-BB44-56E20610DE03</gtr:id><gtr:title>Mps1 Phosphorylates Its N-Terminal Extension to Relieve Autoinhibition and Activate the Spindle Assembly Checkpoint.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10d6ebfe83d3869046d48a777bed7a07"><gtr:id>10d6ebfe83d3869046d48a777bed7a07</gtr:id><gtr:otherNames>Combes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>5aa79142375eb3.84900859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC1C3DC7-9AAE-40EA-98EE-ACFD5A0A4FC7</gtr:id><gtr:title>Biophysical and X-ray crystallographic analysis of Mps1 kinase inhibitor complexes.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a40f0a365b211e74b0c0e37d564203ff"><gtr:id>a40f0a365b211e74b0c0e37d564203ff</gtr:id><gtr:otherNames>Chu ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>SB7o8G5x1cp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A613B289-2244-4AF1-9E0A-356956B4D6C8</gtr:id><gtr:title>Survivin(g) phosphorylation?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca2a9735ed5563c659ea06047c6643bb"><gtr:id>ca2a9735ed5563c659ea06047c6643bb</gtr:id><gtr:otherNames>Eyers P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>058CE37EC18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>332E2892-59FD-45E6-BAE7-B0E66DF32AF8</gtr:id><gtr:title>A framework for identification of actionable cancer genome dependencies in small cell lung cancer.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30a801e1fec423b4ba0986cc9458be32"><gtr:id>30a801e1fec423b4ba0986cc9458be32</gtr:id><gtr:otherNames>Sos ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14412_22_23035247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53FFAE8A-64F8-4813-B286-52EB69FCA433</gtr:id><gtr:title>Rheostat-ing mitosis.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dfc38e1876abc9625afc96ed7e7a1e8"><gtr:id>9dfc38e1876abc9625afc96ed7e7a1e8</gtr:id><gtr:otherNames>Eyers PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_14412_22_23438742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>996C21D8-57F8-4D91-93B1-7FFF25C05113</gtr:id><gtr:title>Protein kinase A is central for forward transport of two-pore domain potassium channels K2P3.1 and K2P9.1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0474ae5e3d82c50153d1d982d4c3f42"><gtr:id>a0474ae5e3d82c50153d1d982d4c3f42</gtr:id><gtr:otherNames>Mant A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14412_22_21357689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6DB93A7-19E3-4F6C-8BE6-73B8F6FF93F1</gtr:id><gtr:title>A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef952ae7c27a45dd37a489a6ea2934f8"><gtr:id>ef952ae7c27a45dd37a489a6ea2934f8</gtr:id><gtr:otherNames>Murphy JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14412_22_24107129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37AD2418-47E3-4755-9A73-8162EF4D6328</gtr:id><gtr:title>Rigorous determination of the stoichiometry of protein phosphorylation using mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society for Mass Spectrometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e886ea4b9b0bb1d209fd0eb4d976a0a2"><gtr:id>e886ea4b9b0bb1d209fd0eb4d976a0a2</gtr:id><gtr:otherNames>Johnson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-0305</gtr:issn><gtr:outcomeId>4F4CB3824DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70E995ED-0CF6-44FF-85E8-A72C25AEF5C8</gtr:id><gtr:title>Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b69af56f8371290060672d2566cd58"><gtr:id>c0b69af56f8371290060672d2566cd58</gtr:id><gtr:otherNames>Sloane DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>WVfdCho4X5Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04EF6AB2-1A38-4193-AE92-51D71742BC5D</gtr:id><gtr:title>Aurora A and Aurora B jointly coordinate chromosome segregation and anaphase microtubule dynamics.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05e07a9123afb13c4d88391acb2cbd07"><gtr:id>05e07a9123afb13c4d88391acb2cbd07</gtr:id><gtr:otherNames>H?garat N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>pm_14412_22_22184196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AE17329-A54F-4660-80B4-AABFB9826E38</gtr:id><gtr:title>Plk4 and Aurora A cooperate in the initiation of acentriolar spindle assembly in mammalian oocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b96c6e0db92b2a93347fffb928f2bde5"><gtr:id>b96c6e0db92b2a93347fffb928f2bde5</gtr:id><gtr:otherNames>Bury L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>5aa79185548342.08518832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5CEE4C0-1B59-4328-8532-5F3BCF875F17</gtr:id><gtr:title>Local protein kinase A action proceeds through intact holoenzymes.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245b98beea502a3b53286d9249e5e2b4"><gtr:id>245b98beea502a3b53286d9249e5e2b4</gtr:id><gtr:otherNames>Smith FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5aa79c4969c5e6.20692675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FD2149F-0E87-4CA6-BF63-E7F35C9C141A</gtr:id><gtr:title>Phosphoregulation of human Mps1 kinase.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63d35cb446702cc244a656ef037242ea"><gtr:id>63d35cb446702cc244a656ef037242ea</gtr:id><gtr:otherNames>Tyler RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>79228A1DD9C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB25E990-B91B-44C4-9A19-D080B68239E9</gtr:id><gtr:title>Mitotic phosphotyrosine network analysis reveals that tyrosine phosphorylation regulates Polo-like kinase 1 (PLK1).</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c94361f45d7aa286f3477129133e52ba"><gtr:id>c94361f45d7aa286f3477129133e52ba</gtr:id><gtr:otherNames>Caron D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>58b42a0dc4dfc5.52093131</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G120/1030</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>